Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016. The American Journal of Managed Care®(AJMC®) thanks everyone who is a part of the franchise’s various social media platforms and who shared, liked, and promoted original research, news, and more all year long.
If you aren’t a part of AJMC®’s social network, join now!
AJMC® Facebook
AJMC® Twitter
AJMC® LinkedIn
AJMC® Instagram
Evidence-Based Oncology™ Twitter
Evidence-Based Diabetes Management™ Twitter
These 5 articles had the most interest on social media networks.
5. When Doctors Go to Business School: Career Choices of Physician—MBAs
An analysis of physicians who graduated from Harvard Business School found the just half (49.3%) remained clinically active in some capacity. Even fewer (27.7%) said that clinical medicine was their primary professional role. The study found that the majority of physician—MBAs diverted from clinical activity. This article, which shed new light into the career outcomes of the growing number of physician–MBAs, was published in the June issue of AJMC®.
4. Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
Not only did the study in this article find that gastric bypass provides benefits beyond weight loss and can actually be more effective than diet and exercise when it comes to reversing type 2 diabetes in people with mild obesity, but the study found the surgery outperformed anti-diabetic drugs. Patients in the study also enjoyed cardiovascular benefits and a reduced risk of cancer.
3. Afrezza: Treating Diabetes in a Physiologic Manner
The September issue of Evidence-Based Diabetes Management™ explored Afrezza, a fast-acting inhaled insulin that has been popular with patients, but had a bad launch. This article highlighted the clinical advantages of Afrezza. Author R. Keith Campbell, MBA, BPharm, CDE, looked at the evidence from studies provided his own personal perspective as someone living with type 1 diabetes.
For more on the situation with Afrezza, check out “5 Things to Know About Afrezza.”
2. Hospital or Home: Building a Better US Maternity Care System (Katy B. Kozhimannil)
AJMC.com contributor Katy B. Kozhimannil, PhD, MPA, looked at a paper published in The New England Journal of Medicine and the debate about which is safer for moms and their babies: to give birth at a hospital or at another setting, such as a birth center or at home? In her article, she weighed the benefits and risks found in the study, and what the findings mean.
If you are interested in becoming an AJMC.com contributor, e-mail Laura Joszt at ljoszt@ajmc.com.
1. Study Finds Alcohol Creates Effects of Fast-Acting Antidepressant
Perhaps it comes as no surprise that an article looking at the effects of alcohol was popular on social media. While the idea that people self-medicated with alcohol to relieve symptoms of depression is not new, a new study looked at the biochemical path and was able to show alcohol produced the same effect being seen in newer rapid-acting antidepressants. Not only does alcohol’s effect on depression occur quickly, but it can last a full day.
Social Media Power: 2016's Most-Read Articles on Facebook, Twitter, and LinkedIn
Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016.
Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016. The American Journal of Managed Care®(AJMC®) thanks everyone who is a part of the franchise’s various social media platforms and who shared, liked, and promoted original research, news, and more all year long.
If you aren’t a part of AJMC®’s social network, join now!
AJMC® Facebook
AJMC® Twitter
AJMC® LinkedIn
AJMC® Instagram
Evidence-Based Oncology™ Twitter
Evidence-Based Diabetes Management™ Twitter
These 5 articles had the most interest on social media networks.
5. When Doctors Go to Business School: Career Choices of Physician—MBAs
An analysis of physicians who graduated from Harvard Business School found the just half (49.3%) remained clinically active in some capacity. Even fewer (27.7%) said that clinical medicine was their primary professional role. The study found that the majority of physician—MBAs diverted from clinical activity. This article, which shed new light into the career outcomes of the growing number of physician–MBAs, was published in the June issue of AJMC®.
4. Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
Not only did the study in this article find that gastric bypass provides benefits beyond weight loss and can actually be more effective than diet and exercise when it comes to reversing type 2 diabetes in people with mild obesity, but the study found the surgery outperformed anti-diabetic drugs. Patients in the study also enjoyed cardiovascular benefits and a reduced risk of cancer.
3. Afrezza: Treating Diabetes in a Physiologic Manner
The September issue of Evidence-Based Diabetes Management™ explored Afrezza, a fast-acting inhaled insulin that has been popular with patients, but had a bad launch. This article highlighted the clinical advantages of Afrezza. Author R. Keith Campbell, MBA, BPharm, CDE, looked at the evidence from studies provided his own personal perspective as someone living with type 1 diabetes.
For more on the situation with Afrezza, check out “5 Things to Know About Afrezza.”
2. Hospital or Home: Building a Better US Maternity Care System (Katy B. Kozhimannil)
AJMC.com contributor Katy B. Kozhimannil, PhD, MPA, looked at a paper published in The New England Journal of Medicine and the debate about which is safer for moms and their babies: to give birth at a hospital or at another setting, such as a birth center or at home? In her article, she weighed the benefits and risks found in the study, and what the findings mean.
If you are interested in becoming an AJMC.com contributor, e-mail Laura Joszt at ljoszt@ajmc.com.
1. Study Finds Alcohol Creates Effects of Fast-Acting Antidepressant
Perhaps it comes as no surprise that an article looking at the effects of alcohol was popular on social media. While the idea that people self-medicated with alcohol to relieve symptoms of depression is not new, a new study looked at the biochemical path and was able to show alcohol produced the same effect being seen in newer rapid-acting antidepressants. Not only does alcohol’s effect on depression occur quickly, but it can last a full day.
How Neighborhood Social Needs Drive Diabetes Care Disparities
October 18th 2024Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
What the Diabetes Health Economy Looks Like in 2024
October 1st 2024The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the role of obesity in these trends.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More
How Neighborhood Social Needs Drive Diabetes Care Disparities
October 18th 2024Unmet social needs in certain neighborhoods contribute to disparities in diabetes care, leading to greater reliance on emergency services, fewer preventive measures, and higher rates of complications.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
What the Diabetes Health Economy Looks Like in 2024
October 1st 2024The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the role of obesity in these trends.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
September 20th 2024The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the US—Caremark, Express Scripts, and Optum Rx—of inflating insulin costs for patients, prompting renewed calls for PBM reform.
Read More
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes
September 5th 2024This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Read More